Loading...
Pharmagreen Biotech Inc.
PHBI•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.001
$0.00(10.00%)
Pharmagreen Biotech Inc. (PHBI) Stock Overview
Explore Pharmagreen Biotech Inc.’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
13.74%
↑ 13.74%
Profit Growth
$-0.00
↓ 76.59%
EPS Growth
$-0.00
↓ 25.00%
Operating Margin
-7807.79%
↑ 47.64%
ROE
9.06%
↓ 76.59%
Dividend Yield
0.00%
Analyst Recommendations data is not available for PHBIAnalyst Recommendations details for PHBI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada.
CEO
Mr. Peter Wojcik B.A.
Headquarters
2987 Blackbear Court, Coquitlam, BC
Founded
2018